ID
24157
Beskrivning
Study ID: 100716 Clinical Study ID: NKP100716 Study Title: An open label repeat dose study to investigate the effect of GW597599 (15 mg) and paroxetine (10 mg) given in combination for 15 days on the pharmacokinetics of midazolam and dextromethorphan in healthy male and female volunteers Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 1 Study Recruitment Status: Completed Generic Name: vestipitant Trade Name: paroxetine and vestipitant Study Indication: Depressive Disorder and Anxiety Disorders Documentation part: Serious Adverse Event, Investigator's Statement
Nyckelord
Versioner (1)
- 2017-07-26 2017-07-26 -
Rättsinnehavare
GlaxoSmithKline
Uppladdad den
26 juli 2017
DOI
För en begäran logga in.
Licens
Creative Commons BY-NC 3.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
GW597599 and paroxetine on the pharmacokinetics of midazolam and dextromethorphan 100716 Serious Adverse Event (SAE), Investigator's Statement
GW597599 and paroxetine on the pharmacokinetics of midazolam and dextromethorphan 100716 Serious Adverse Event (SAE), Investigator's Statement
Beskrivning
Investigator's Checklist
Alias
- UMLS CUI-1
- C1707357
- UMLS CUI-2
- C0008961
Beskrivning
baseline signs and symptoms
Datatyp
boolean
Alias
- UMLS CUI [1]
- C0037088
Beskrivning
prior medication
Datatyp
boolean
Alias
- UMLS CUI [1]
- C0013227
Beskrivning
signatures and dates
Datatyp
boolean
Alias
- UMLS CUI [1]
- C2346576
- UMLS CUI [2]
- C0011008
Beskrivning
laboratory
Datatyp
boolean
Alias
- UMLS CUI [1]
- C0022877
Beskrivning
correct, complete recording
Datatyp
text
Alias
- UMLS CUI [1,1]
- C0034869
- UMLS CUI [1,2]
- C2349182
- UMLS CUI [1,3]
- C0205197
Similar models
GW597599 and paroxetine on the pharmacokinetics of midazolam and dextromethorphan 100716 Serious Adverse Event (SAE), Investigator's Statement
C1442488 (UMLS CUI [1,2])
C3853704 (UMLS CUI [1,2])
C0580673 (UMLS CUI [1,2])
C0034897 (UMLS CUI [1,2])
C0439849 (UMLS CUI [1,2])
C1519255 (UMLS CUI [1,3])
C0087111 (UMLS CUI [1,2])
C0877248 (UMLS CUI [1,2])
C0011008 (UMLS CUI [1,2])
C0947611 (UMLS CUI [1,2])
C0237753 (UMLS CUI [1,2])
C0008961 (UMLS CUI-2)
C0011008 (UMLS CUI [2])
C2349182 (UMLS CUI [1,2])
C0205197 (UMLS CUI [1,3])
Inga kommentarer